SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Genenta Science S.p.A. (GNTA) has a negative trailing P/E of -2.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.9 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -50.28%, forward earnings yield 109.89%. PEG 0.01 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -2.0); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -50.28%).
- Forward P/E 0.9 — analysts expect a return to profitability with estimated EPS of $0.71 for FY2029.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield -50.28% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 109.89% as earnings recover.
Overall SharesGrow Score: 46/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GNTA
Valuation Multiples
P/E (TTM)-2.0
Forward P/E0.9
PEG Ratio0.01
Forward PEG0.01
P/B Ratio0.59
P/S Ratio0.00
EV/EBITDA-2.1
Per Share Data
EPS (TTM)$-0.31
Forward EPS (Est.)$0.71
Book Value / Share$1.03
Revenue / Share$0.00
FCF / Share$-0.08
Yields & Fair Value
Earnings Yield-50.28%
Forward Earnings Yield109.89%
Dividend Yield0.00%
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-38.6 |
0.00 |
9.43 |
0.00 |
- |
| 2020 |
-29.1 |
-1.21 |
10.76 |
0.00 |
- |
| 2021 |
-31.8 |
0.00 |
4.52 |
0.00 |
- |
| 2022 |
-11.0 |
-0.21 |
3.00 |
0.00 |
- |
| 2023 |
-7.0 |
-0.19 |
3.99 |
0.00 |
- |
| 2024 |
-8.6 |
0.37 |
6.14 |
0.00 |
- |
| 2025 |
-3.8 |
0.12 |
1.14 |
0.00 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.25 |
$0.00 |
$-4.61M |
- |
| 2020 |
$-0.31 |
$0.00 |
$-5.61M |
- |
| 2021 |
$-0.31 |
$0.00 |
$-5.56M |
- |
| 2022 |
$-0.20 |
$0.00 |
$-3.62M |
- |
| 2023 |
$-0.64 |
$0.00 |
$-11.65M |
- |
| 2024 |
$-0.49 |
$0.00 |
$-8.91M |
- |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-0.45 |
$-0.45 – $-0.45 |
$0.00 |
$0.00 – $0.00 |
1 |
| 2027 |
$-0.52 |
$-0.52 – $-0.52 |
$0.00 |
$0.00 – $0.00 |
1 |
| 2028 |
$-0.19 |
$-0.19 – $-0.19 |
$30.04M |
$30.04M – $30.04M |
1 |
| 2029 |
$0.70 |
$0.70 – $0.70 |
$0.00 |
$0.00 – $0.00 |
1 |
| 2030 |
$1.72 |
$1.72 – $1.72 |
$0.00 |
$0.00 – $0.00 |
1 |
